Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the humanized anti-soluble aggregated amyloid-beta (A?) monoclonal antibody "LEQEMBI®" has been ...

Cambridge Day is raising money and plans to hire a publisher, editor-in-chief, and reporters to expand the organization.

In this groundbreaking edition of the King James Version, David Norton painstakingly collated the established text of the KJV with the Translators’ original notes. He presented the text as intended by ...